TW200510395A - Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor - Google Patents

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Info

Publication number
TW200510395A
TW200510395A TW093116262A TW93116262A TW200510395A TW 200510395 A TW200510395 A TW 200510395A TW 093116262 A TW093116262 A TW 093116262A TW 93116262 A TW93116262 A TW 93116262A TW 200510395 A TW200510395 A TW 200510395A
Authority
TW
Taiwan
Prior art keywords
dopamine
respond
treating disorders
receptor
modulation
Prior art date
Application number
TW093116262A
Other languages
English (en)
Inventor
Andreas Haupt
Roland Grandel
Wilfried Braje
Herve Geneste
Karla Drescher
Dorothea Starck
Hans-Jurgen Teschendorf
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of TW200510395A publication Critical patent/TW200510395A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW093116262A 2003-06-05 2004-06-04 Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor TW200510395A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45551403A 2003-06-05 2003-06-05

Publications (1)

Publication Number Publication Date
TW200510395A true TW200510395A (en) 2005-03-16

Family

ID=33159567

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093116262A TW200510395A (en) 2003-06-05 2004-06-04 Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Country Status (6)

Country Link
EP (1) EP1484330B1 (zh)
JP (1) JP2004359689A (zh)
AT (1) ATE307811T1 (zh)
DE (1) DE602004000158T2 (zh)
TW (1) TW200510395A (zh)
WO (1) WO2004108706A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101754B2 (en) * 2004-12-02 2012-01-24 Abbott Gmbh & Co. Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
US8318931B2 (en) 2005-10-28 2012-11-27 Ono Pharmaceutical Co., Ltd. Chemokine receptor antagonists and use thereof
PA8802101A1 (es) * 2007-11-02 2009-08-26 Abbott Gmbh & Co Kg Compuestos de 1,2,4-3,5-diona adecuados para el tratamiento de trastornos que responden a la modulación del receptor de dopamina d3
US9376396B2 (en) 2012-10-22 2016-06-28 AbbVie Deutschland GmbH & Co. KG Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
AR095264A1 (es) 2013-03-15 2015-09-30 Abbvie Deutschland Compuestos de acilaminocicloalquilo apropiados para tratar trastornos que responden a la modulación del receptor de dopamina d3
UY35420A (es) 2013-03-15 2014-10-31 Abbvie Inc Compuestos de acilaminocicloalquilo apropiados para tratar trastornos que responden a la modulación del receptor de dopamina d3
WO2017181004A1 (en) * 2016-04-14 2017-10-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Selective d3 dopamine receptor agonists and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung

Also Published As

Publication number Publication date
DE602004000158D1 (de) 2005-12-01
WO2004108706A1 (en) 2004-12-16
ATE307811T1 (de) 2005-11-15
EP1484330B1 (en) 2005-10-26
JP2004359689A (ja) 2004-12-24
EP1484330A1 (en) 2004-12-08
DE602004000158T2 (de) 2006-07-27

Similar Documents

Publication Publication Date Title
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
TWI265931B (en) Composition and method for inhibiting platelet aggregation
TWI255807B (en) Therapeutic agents
SE0400235D0 (sv) New composition containing quinoline compounds
WO2005097814A3 (en) Composition and method for inhibiting platelet aggregation
WO2006119507A3 (en) Non-nucleotide composition and method for inhibiting platelet aggregation
EA200870448A1 (ru) Тризамещенные 1,2,4-триазолы
MXPA04012998A (es) Modulares de receptores nucleares de hormonas esteroideas triciclicos.
EA023500B1 (ru) Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты
AP2001002307A0 (en) B3 adrenergic receptor agonists and uses thereof.
MY151295A (en) Pyrimidyl indoline compound
TW200726764A (en) N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
TW200716547A (en) Piperidin-4-yl-amide derivatives
DE602005017162D1 (de) 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i
TW200633710A (en) Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
TN2009000452A1 (en) [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof
DE602004027409D1 (de) Tetrahydrofuroä3,4-düdioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation
MX2023000943A (es) Compuestos de tetrahidropirazolo-pirazinil-dihidroimidazolona o tetrahidropirazolo-piridinil-dihidroimidazolona y metodos de uso de los mismos.
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
WO2007125398A3 (en) : sulfonamide compounds as antagonists of the n-type calcium channel
TW200510395A (en) Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
MY154066A (en) 1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
TW200600013A (en) 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
MY153733A (en) Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
DK1256581T3 (da) Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation